Does Elevated Pre-Treatment Plasma PD-L1 Level Indicate an Increased Tumor Burden and Worse Prognosis in Metastatic Colorectal Cancer?

Background: Programmed death-ligand 1 (PD-L1) and programmed cell death protein 1 (PD-1) have been reported as possibly favorable prognostic factors in colorectal cancer (CRC). However, their longitudinal effect is unknown. Methods: A pilot study was performed to investigate whether baseline PD-1/PD...

Descripción completa

Detalles Bibliográficos
Autores principales: Dank, Magdolna, Mühl, Dorottya, Herold, Magdolna, Hornyák, Lilla, Szasz, Attila Marcell, Herold, Zoltan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410536/
https://www.ncbi.nlm.nih.gov/pubmed/36013050
http://dx.doi.org/10.3390/jcm11164815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410536/
https://www.ncbi.nlm.nih.gov/pubmed/36013050
http://dx.doi.org/10.3390/jcm11164815

Ejemplares similares